{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:59:46Z","timestamp":1769666386991,"version":"3.49.0"},"reference-count":0,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/ymdr2167","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:09:25Z","timestamp":1769483365000},"page":"268-281","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy and safety of bispecific antibody teclistamab versus CAR-T cell therapies in relapsed\/refractory multiple myeloma: a retrospective evaluation"],"prefix":"10.62347","volume":"16","author":[{"given":"Yanjun","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"container-title":["American Journal of Cancer Research"],"original-title":[],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:10:17Z","timestamp":1769483417000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/16\/1\/ajcr0169427.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/ymdr2167","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}